课题基金 / 基金详情

Optimizing Selection and Management of Cardiac Arrest Patients Treated with ECMO

Optimizing Selection and Management of Cardiac Arrest Patients Treated with ECMO
优化接受 ECMO 治疗的心脏骤停患者的选择和管理
批准号:
10400018
负责人:
Joseph Edward Tonna
金额:
$18.9万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-06-15 至 2024-04-30

项目摘要

项目成果

Joseph Edward Tonna的其他基金

相似基金

相关文献

中文摘要
翻译
项目摘要/摘要 这是约瑟夫·唐纳博士的K23奖项申请书,他是一名接受过急救医学培训的强化医生 犹他大学。唐纳医生在以病人为中心的临床领域确立了自己的年轻研究员的地位。 体外膜肺氧合等抢救疗法的应用与验证研究 (ECMO)。这项K23奖项将为Tonna博士提供必要的支持,以实现以下目标: (1)发展调查设计和定性评估方面的专门知识,以支持临床试验;(2)发展 社区参与和研究道德方面的专业知识,以改进临床指导和设计 研究,(3)在设计和实施多中心临床试验方面发展专业知识,以及(4) 发展独立的临床研究事业。为了实现这些目标,唐纳博士组建了一个 由主要导师Heather Keenan博士组成的指导团队,Heather Keenan博士是一名集约主义者和流行病学家 进行了大型前瞻性结果研究,以及两位共同导师:急诊医生兰斯·贝克尔博士 和心脏骤停研究的公认领导者,以及研究伦理和研究专家杰弗里·博特金博士 社区参与。Tonna博士还有四名顾问,他们在临床试验、ECMO、定性 评估、调查设计和社区参与。 心脏骤停复苏的主要治疗方法是心肺复苏术(CPR)。 功效。多达88%的心脏骤停患者死亡。Tonna博士的研究为临床试验做准备 ECMO在心肺复苏(称为体外心肺复苏/心肺复苏术)过程中启动的新疗法前景看好。唐娜博士 将(目标1)描述ECPR的患者选择标准和管理实践,这些标准和管理实践与 神经功能完整的存活率;(目标2)生成ECPR试验设计选择标准和管理 医生可接受;(目标3)确定ECPR试验的试验设计和方案特征 不同社区可以接受的知情同意的例外情况。在《目标1》中,唐娜博士将 分析国家ECPR数据集,学习高级统计建模。调查结果将为优化设计提供参考 心肺复苏试验。在目标2中,唐娜博士将采访执业医生,以产生和管理国家 调查以确定ECPR试验要素的可接受性。在《目标3》中,唐娜博士将表演社区 参与制定未来ECPR试验的设计和实施战略,使用 知情同意的例外。SA2和SA3的结果将通知可接受的ECPR试验 医生和不同的社区。这项研究将为Tonna博士设计和实施 科学严谨、合乎道德的ECPR试验。
英文摘要
PROJECT SUMMARY/ABSTRACT This is an application for a K23 award for Dr. Joseph Tonna, an emergency medicine trained intensivist at the University of Utah. Dr. Tonna is establishing himself as a young investigator in patient-oriented clinical research in the application and validation of rescue therapies such as extracorporeal membrane oxygenation (ECMO). This K23 award will provide Dr. Tonna with the support necessary to accomplish the following goals: (1) to develop expertise in survey design and qualitative assessment to support clinical trials, (2) develop expertise in community engagement and research ethics to improve the conduct and design of clinical research, (3) to develop expertise in the design and implementation multi-center clinical trials, and (4) to develop an independent clinical research career. To achieve these goals, Dr. Tonna has assembled a mentoring team comprising a primary mentor, Dr. Heather Keenan, an intensivist and epidemiologist who has performed large prospective outcome studies, and two co-mentors: Dr. Lance Becker, an emergency physician and recognized leader in cardiac arrest research, and Dr. Jeffrey Botkin, an expert in research ethics and community engagement. Dr. Tonna also has four advisors with expertise in clinical trials, ECMO, qualitative assessments, survey design and community engagement. The main therapy of cardiac arrest resuscitation is cardiopulmonary resuscitation (CPR), which has limited efficacy. As many as 88% of patients in cardiac arrest die. Dr. Tonna’s research prepares for clinical trials of a promising novel treatment in which ECMO is started during CPR (called extracorporeal CPR/eCPR). Dr. Tonna will (Aim 1) characterize patient selection criteria and management practices for eCPR that are associated with neurologically intact survival; (Aim 2) generate eCPR trial design selection criteria and management acceptable to physicians; (Aim 3) determine trial design and protocol features for eCPR trials conducted with an exception from informed consent that are acceptable to diverse communities. In Aim 1, Dr. Tonna will analyze a national eCPR dataset, learning advanced statistical modeling. Findings will inform optimal design of eCPR trials. In Aim 2, Dr. Tonna will interview practicing physicians to generate and administer a national survey to determine the acceptability of eCPR trial elements. In Aim 3, Dr. Tonna will perform community engagement to generate design and implementation strategies for future eCPR trials conducted using exception from informed consent. Results of SA2 and SA3 will inform eCPR trials that are acceptable to physicians and to diverse communities. This research will prepare Dr. Tonna to design and implement scientifically rigorous and ethical eCPR trials.
期刊论文(39)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1097/ccm.0000000000005466
发表时间: 2022-06-01
期刊: Critical care medicine
影响因子: 8.8
作者: []
通讯作者:
DOI: 10.1161/jaha.123.032288
发表时间: 2024-01
期刊: Journal of the American Heart Association
影响因子: 5.4
作者: [J. Jentzer;S. Drakos;C. Selzman;Clark G Owyang;Felipe Teran;J. Tonna]
通讯作者: J. Jentzer;S. Drakos;C. Selzman;Clark G Owyang;Felipe Teran;J. Tonna
Pulmonary Artery Pressures and Mortality during VA ECMO: An ELSO Registry Analysis.
VA ECMO 期间的肺动脉压力和死亡率:ELSO 登记分析。
DOI: 10.1101/2023.08.08.23293859
发表时间: 2023
期刊: medRxiv : the preprint server for health sciences
影响因子: --
作者: [Owyang,ClarkG, Rippon,Brady, Teran,Felipe, Brodie,Daniel, Araos,Joaquin, Burkhoff,Daniel, Kim,Jiwon, Tonna,JosephE]
通讯作者: Tonna,JosephE
DOI: 10.1016/j.jacc.2022.01.032
发表时间: 2022-04-05
期刊: JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
影响因子: 24
作者: [Grandin, E. Wilson, Nunez, Jose, I, Willar, Brooks, Kennedy, Kevin, Rycus, Peter, Tonna, Joseph E., Kapur, Navin K., Shaefi, Shahzad, Garan, A. Reshad]
通讯作者: Garan, A. Reshad
共 28 条
    Optimizing Selection and Management of Cardiac Arrest Patients Treated with ECMO
    • 批准号:
      9921472
    • 项目类别:
    • 资助金额:
      $18.9万
    • 财政年份:
      2018
    • 负责人:
      Joseph Edward Tonna
    • 依托单位:
    海外基金